About Madisyn

Madisyn Lu is a Senior Program Manager for diagnostics and viral hepatitis at the Clinton Health Access Initiative. She has been working with teams across seven countries in Africa and Asia to scale up national programs for testing and treatment of hepatitis. Madisyn previously helped launch the CHAI Sierra Leone office in the midst of the Ebola crisis in 2015 – leading a program focused on rebuilding and strengthening the supply chain to deliver essential medicines nationwide. Madisyn’s other past roles at CHAI include planning and policy support for reduced childhood mortality from diarrhea & pneumonia and improved access to drugs and treatment for PLHIV. Prior to CHAI, Madisyn worked in management consulting at Oliver Wyman with experience in retail, healthcare, transportation, private equity, and finance sectors.

This speaker will be presenting at the following session(s)

  • Options for countries with access to generic hepatitis medicines

    Ballroom 2

    Day: 2 November

    Time: 12:00

    Chair: Dr. Jean Damascène Makuza, Rwanda Biomedical Center and Tracy Swan, Médecins Sans Frontières


    • Country example: Rwanda.
      Dr. Jean Damascène Makuza, Rwanda Biomedical Center
    • The impact of generics in scaling up treatment.
    • Dr. Saeed Hamid, The Aga Khan University, Pakistan
    • Voluntary licensing.
      Greg Perry, Medicines Patent Pool
    • Basics of access to medicines for hepatitis programme managers.
    • Madisyn Lu, Clinton Health Access Initiative
    • Q & A session.